PTAB accepts Bass’s toenail patent challenges

25-02-2016

PTAB accepts Bass’s toenail patent challenges

relif / Shutterstock.com

The Coalition for Affordable Drugs and Anacor Pharmaceuticals will face off in a dispute over the validity of two anti-fungal patents after the Patent Trial and Appeal Board (PTAB) gave the go-ahead to two inter partes review petitions.


PTAB; USPTO; IPR; Anacor Pharmaceuticals; Kyle Bass;

LSIPR